Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Under Armour Inc Class A (UAA) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Under Armour Inc Class ATrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Under Armour Inc Class A vs Vir Biotechnology Inc. Common Stock — how do they compare? Under Armour Inc Class A trades at $4.79 (market cap $2.08B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Under Armour Inc Class A is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Under Armour Inc Class A for 99 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

UAAVIR
Market Cap
$2.08B$1.80B
Volume
7,012,0201,782,836
Sector
Consumer CyclicalHealth
52-Week High
$8.14$11.78
52-Week Low
$4.17$5.12
Typical Hold Time
99 Days0 Days
Enterprise Value
$3.06B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Under Armour Inc Class A

Under Armour (UAA) trades at $4.79, down 2.84% on the day, amid mixed signals. The stock shows a bullish technical trend but faces fundamental headwinds with a net loss of $201.27M in 2025 and negative profit margins. Recent news highlights the company's focus on product simplification and margin recovery despite revenue weakness, with Q1 2027 earnings beating estimates but revenue falling short.

The outlook is cautious; while cost discipline supports margins, persistent revenue declines and negative cash flow pose risks. Analyst consensus is a 'Hold' with a $5.79 price target, suggesting limited upside. Investors should weigh margin improvements against top-line challenges and high short interest, which could lead to volatility.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

UAA
92% Buy8% Sell
Avg holding period · 99 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Under Armour Inc Class A

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.

Read more on UAA →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →